Table 3 Recurrence pattern and PFS in patients
Recurrence pattern | Plan1 | Plan2 | Astrocytoma (N = 21) | Oligodendroglioma(N = 3) | GBM (N = 66) | Plan1 | Plan2 | Plan1 | Plan2 |
|---|---|---|---|---|---|---|---|---|---|
| Â | n (%) | n (%) | mPFS (range) | Recurrence within 6Â months (%) | |||||
Central | 31 (64.6) | 27 (64.3) | 11 (52.4) | 2 (66.7) | 45 (68.2) | 5.5 (1.1–30.8) | 6.7 (1.2–33.5) | 51.6 | 40.7 |
In-field | 4 (8.3) | 6 (14.3) | 3 (14.3) | 0 | 7 (10.6) | 9.1 (1.5–10.5) | 4.7 (1.7–27.5) | 25 | 50 |
Marginal | 2 (4.1) | 1 (2.3) | 2 (9.5) | 1 (33.3) | 0 | 2.4 (2.4–30.4) | 6.1 | 50 | 0 |
Distant | 7 (14.6) | 4 (9.5) | 3 (14.3) | 0 | 8 (12.1) | 10.1 (5.7–24.2) | 9.8 (8.3–31.4) | 0 | 0 |
CSF-d | 4 (8.3) | 4 (9.5) | 2 (9.5) | 0 | 6 (9.1) | 5.0 (3.7–18.9) | 10.9 (2.3–24.7) | 50 | 0 |